Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Hackshaw

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Prenatal Diagnosis|February 17, 2001
Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defectsA K Hackshaw, N J Wald, L M George
BMJ (Clinical Research Ed.)|December 11, 1999
When can a risk factor be used as a worthwhile screening test?N J Wald, A K Hackshaw, C D Frost
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Maternal serum alphafetoprotein screening for open neural tube defects: revised statistical parametersN J Wald, A K Hackshaw, H S Cuckle
BMJ (Clinical Research Ed.)|November 20, 1997
The accumulated evidence on lung cancer and environmental tobacco smokeA K Hackshaw, M R Law, N J Wald
Journal of Medical Screening|September 26, 2000
Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndromeN J Wald, A K Hackshaw, L M George
The New England Journal of Medicine|August 12, 1999
Integrated screening for Down's syndrome based on tests performed during the first and second trimestersN J Wald, H C Watt, A K Hackshaw
Lancet (London, England)|December 21, 1996
Down's syndrome screening with nuchal translucencyA K Hackshaw, N J Wald, J E Haddow
BJOG : an International Journal of Obstetrics and Gynaecology|June 17, 2004
SURUSS in perspectiveN J Wald, C Rodeck, A K Hackshaw, et al.
Seminars in Perinatology|August 18, 2005
SURUSS in perspectiveN J Wald, C Rodeck, A K Hackshaw, et al.
Journal of Medical Screening|January 1, 1996
Empirical validation of risk screening for Down's syndromeN J Wald, A K Hackshaw, W Huttly, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Prenatal Diagnosis|February 17, 2001
Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defectsA K Hackshaw, N J Wald, L M George
BMJ (Clinical Research Ed.)|December 11, 1999
When can a risk factor be used as a worthwhile screening test?N J Wald, A K Hackshaw, C D Frost
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Maternal serum alphafetoprotein screening for open neural tube defects: revised statistical parametersN J Wald, A K Hackshaw, H S Cuckle
BMJ (Clinical Research Ed.)|November 20, 1997
The accumulated evidence on lung cancer and environmental tobacco smokeA K Hackshaw, M R Law, N J Wald
Journal of Medical Screening|September 26, 2000
Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndromeN J Wald, A K Hackshaw, L M George
The New England Journal of Medicine|August 12, 1999
Integrated screening for Down's syndrome based on tests performed during the first and second trimestersN J Wald, H C Watt, A K Hackshaw
Lancet (London, England)|December 21, 1996
Down's syndrome screening with nuchal translucencyA K Hackshaw, N J Wald, J E Haddow
BJOG : an International Journal of Obstetrics and Gynaecology|June 17, 2004
SURUSS in perspectiveN J Wald, C Rodeck, A K Hackshaw, et al.
Seminars in Perinatology|August 18, 2005
SURUSS in perspectiveN J Wald, C Rodeck, A K Hackshaw, et al.
Journal of Medical Screening|January 1, 1996
Empirical validation of risk screening for Down's syndromeN J Wald, A K Hackshaw, W Huttly, et al.
Pageof 4